Brian Cheng
Stock Analyst at J.P. Morgan
(4.22)
# 1,515
Out of 5,051 analysts
289
Total ratings
47.3%
Success rate
8.8%
Average return
Main Sectors:
Stocks Rated by Brian Cheng
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics | Maintained: Buy | n/a | $24.17 | - | 2 | Oct 13, 2026 | |
| ABSI Absci | Reiterated: Buy | $15 | $9.67 | +55.12% | 2 | Oct 12, 2026 | |
| AAPG Ascentage Pharma Group International | Reiterated: Buy | $46 → $33 | $15.31 | +115.55% | 7 | Oct 8, 2026 | |
| ABCL AbCellera Biologics | Initiated Coverage: Buy | $17 | $12.64 | +34.55% | 1 | Sep 29, 2026 | |
| KYMR Kymera Therapeutics | Reiterated: Buy | $140 | $112.08 | +24.91% | 9 | Sep 28, 2026 | |
| DNTH Dianthus Therapeutics | Reiterated: Buy | n/a | $81.57 | - | 2 | Sep 24, 2026 | |
| BLSM BlossomHill Therapeutics | Reiterated: Buy | $30 | $17.27 | +73.71% | 3 | Sep 23, 2026 | |
| ROIV Roivant Sciences | Reiterated: Buy | n/a | $34.59 | - | 27 | Sep 17, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | n/a | $60.73 | - | 6 | Sep 15, 2026 | |
| XNCR Xencor | Reiterated: Hold | $14 → $21 | $25.04 | -16.13% | 16 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $25.33 | +30.28% | 14 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $246 | $193.95 | +26.84% | 18 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $149 | $144.88 | +2.84% | 24 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.40 | - | 9 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $7.26 | +299.45% | 5 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $0.986 | - | 3 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $13 | $6.09 | +113.46% | 2 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $27 | $10.52 | +156.65% | 3 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $29.48 | +69.61% | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $29 | $18.26 | +58.82% | 2 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $72 | $55.27 | +30.27% | 4 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $25.13 | +75.09% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $89 → $91 | $62.92 | +44.63% | 10 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.78 | - | 5 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.15 | - | 9 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $6.21 | +366.99% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 | $12.58 | -36.41% | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $96 | $63.13 | +52.07% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $2.75 | - | 7 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $69 → $67 | $51.55 | +29.97% | 3 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.38 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $7.66 | n/a | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.86 | n/a | 8 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.03 | n/a | 1 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $6 | $1.02 | n/a | 2 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $6 | $5.53 | n/a | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $0.3186 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $9.28 | n/a | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $3.5 | $1.62 | n/a | 2 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $17 | $8.36 | n/a | 6 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.5974 | n/a | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93 → $86 | $12.61 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.50 | n/a | 2 | Nov 2, 2021 |
Tango Therapeutics
Oct 13, 2026
Maintained: Buy
Price Target: n/a
Current: $24.17
Upside: -
Absci
Oct 12, 2026
Reiterated: Buy
Price Target: $15
Current: $9.67
Upside: +55.12%
Ascentage Pharma Group International
Oct 8, 2026
Reiterated: Buy
Price Target: $46 → $33
Current: $15.31
Upside: +115.55%
AbCellera Biologics
Sep 29, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $12.64
Upside: +34.55%
Kymera Therapeutics
Sep 28, 2026
Reiterated: Buy
Price Target: $140
Current: $112.08
Upside: +24.91%
Dianthus Therapeutics
Sep 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $81.57
Upside: -
BlossomHill Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $30
Current: $17.27
Upside: +73.71%
Roivant Sciences
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $34.59
Upside: -
Arrowhead Pharmaceuticals
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $60.73
Upside: -
Xencor
Sep 3, 2026
Reiterated: Hold
Price Target: $14 → $21
Current: $25.04
Upside: -16.13%
Sep 3, 2026
Reiterated: Buy
Price Target: $33
Current: $25.33
Upside: +30.28%
Sep 1, 2026
Reiterated: Buy
Price Target: $246
Current: $193.95
Upside: +26.84%
Aug 31, 2026
Reiterated: Buy
Price Target: $149
Current: $144.88
Upside: +2.84%
Aug 17, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.40
Upside: -
Aug 17, 2026
Reiterated: Buy
Price Target: $29
Current: $7.26
Upside: +299.45%
Aug 17, 2026
Reiterated: Sell
Price Target: n/a
Current: $0.986
Upside: -
Aug 12, 2026
Reiterated: Buy
Price Target: $10 → $13
Current: $6.09
Upside: +113.46%
Aug 10, 2026
Reiterated: Buy
Price Target: $31 → $27
Current: $10.52
Upside: +156.65%
Aug 10, 2026
Reiterated: Buy
Price Target: $50
Current: $29.48
Upside: +69.61%
Aug 10, 2026
Reiterated: Buy
Price Target: $26 → $29
Current: $18.26
Upside: +58.82%
Aug 10, 2026
Reiterated: Buy
Price Target: $65 → $72
Current: $55.27
Upside: +30.27%
Aug 6, 2026
Reiterated: Buy
Price Target: $44
Current: $25.13
Upside: +75.09%
Jul 13, 2026
Reiterated: Buy
Price Target: $89 → $91
Current: $62.92
Upside: +44.63%
Jun 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.78
Upside: -
Jun 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.15
Upside: -
May 13, 2026
Rated: Buy
Price Target: $29
Current: $6.21
Upside: +366.99%
May 13, 2026
Reiterated: Sell
Price Target: $8
Current: $12.58
Upside: -36.41%
May 11, 2026
Rated: Buy
Price Target: $96
Current: $63.13
Upside: +52.07%
Mar 13, 2026
Reiterated: Sell
Price Target: n/a
Current: $2.75
Upside: -
Feb 13, 2026
Reiterated: Buy
Price Target: $69 → $67
Current: $51.55
Upside: +29.97%
Nov 20, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $1.38
Upside: -
Aug 15, 2025
Upgraded: Hold
Price Target: n/a
Current: $7.66
Upside: n/a
Mar 21, 2025
Rated: Hold
Price Target: n/a
Current: $1.86
Upside: n/a
Jul 15, 2024
Reiterated: Hold
Price Target: n/a
Current: $1.03
Upside: n/a
May 2, 2024
Downgraded: Hold
Price Target: $16 → $6
Current: $1.02
Upside: n/a
Jun 1, 2023
Downgraded: Hold
Price Target: $20 → $6
Current: $5.53
Upside: n/a
Dec 16, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $0.3186
Upside: n/a
Dec 7, 2022
Downgraded: Sell
Price Target: n/a
Current: $9.28
Upside: n/a
Apr 19, 2022
Reiterated: Buy
Price Target: $33 → $3.5
Current: $1.62
Upside: n/a
Apr 8, 2022
Reiterated: Buy
Price Target: $21 → $17
Current: $8.36
Upside: n/a
Apr 4, 2022
Reiterated: Buy
Price Target: $12
Current: $0.5974
Upside: n/a
Mar 1, 2022
Reiterated: Buy
Price Target: $93 → $86
Current: $12.61
Upside: n/a
Nov 2, 2021
Reiterated: Buy
Price Target: $14
Current: $1.50
Upside: n/a